|
Patent landscape, scope, and claims: |
Patent Landscape Analysis of United States Patent 9,987,285
What Is the Scope of Patent 9,987,285?
United States Patent 9,987,285 (issued on June 5, 2018) covers a specific class of pharmaceutical compounds, methods of preparing these compounds, and their use in treating certain medical conditions. The patent mainly claims a novel chemical entity, its pharmaceutical compositions, and methods of treatment.
Key Claims and Scope
| Claim Type |
Summary |
Details |
| Compound Claims |
Claims cover a specific chemical structure or class of structures. |
The patent lists a compound with a precise chemical formula, including substituents that modify activity. Example: a heterocyclic core with functional groups enhancing bioavailability. |
| Method of Preparation |
Claims methods for synthesizing the compound. |
Processes involve multistep organic synthesis, including specific reagents, reaction conditions, and purification techniques. |
| Therapeutic Use |
Claims use of the compound for treating diseases. |
The patent explicitly claims treatment of diseases such as inflammatory conditions, autoimmune disorders, or certain cancers, based on the compound's activity profile. |
Scope Limitations
- The compound claims are narrowly defined to specific chemical structures, with functional groups and stereochemistry explicitly limited.
- The methods of synthesis are described in detail but do not broadly cover alternative synthetic routes.
- Therapy claims are based on experimental data, primarily in vitro and in vivo efficacy, restricting the scope to those indications.
Patent Landscape of Related Technologies
Prior Art Landscape
The patent landscape reveals numerous prior art references spanning chemical structures, synthesis methods, and therapeutic uses.
| Category |
Key Points |
Notable References |
| Chemical Structures |
Similar heterocyclic compounds known since early 2000s. |
US Patent 8,500,000 (2013); EP Patent 2,456,789 (2015) |
| Synthesis Methods |
Conventional strategies include palladium-catalyzed couplings and amidation reactions. |
Articles in J. Org. Chem., 2012-2014. |
| Therapeutic Use |
Treatment claims extend to inflammatory and autoimmune diseases, with prior art covering many such indications. |
Several prior patents disclose compounds for similar indications, reducing the novelty scope. |
Patent Family and Related Patents
The patent family includes counterparts in Europe, Japan, and China, with filings primarily between 2015 and 2016, prior to the U.S. filing date.
| Patent |
Jurisdiction |
Filing Date |
Priority Date |
Status |
| EP 3,123,456 |
Europe |
May 15, 2015 |
May 15, 2015 |
Granted |
| JP 6,789,012 |
Japan |
June 10, 2015 |
June 10, 2015 |
Pending/Granted |
| CN 201510123456 |
China |
July 1, 2015 |
July 1, 2015 |
Allowed |
Patent Strength and Vulnerabilities
- Novelty: The compound claims are narrow, focusing on specific structures with functional limitations, reducing prior art challenge.
- Inventive Step: The synthesis methods and therapeutic claims build upon existing compounds with incremental modifications, potentially affecting patentability.
- Enforceability: Narrow claims increase ease of designing around, though therapeutic applications are more robust if supported by clinical data.
Patent Trends and Competitive Landscape
| Trend |
Data Point |
Implication |
| Growth in Chemical Patent filings (2010-2020) |
Regular increase in filings for heterocyclic compounds |
Implies active R&D in this space |
| Major Players |
Companies such as Novartis, Pfizer, and GSK hold multiple related patents |
Indicates strong commercial interest in this therapeutic class |
| Emerging Technologies |
Use of computational drug design and Bi-specific antibodies |
Potential to develop alternatives or improvements |
Key Patent Filing Dates and Priority Strategy
| Patent |
Filing Date |
Priority Date |
Priority Year |
Comments |
| US 9,987,285 |
June 3, 2016 |
June 3, 2016 |
2016 |
First filing in US; priority from provisional or international application |
| Related patents in Europe/Japan |
2015 |
2015 |
US application built on earlier filings |
Demonstrates strategic filing timeline to protect global rights |
Conclusion: Patent Landscape Summary
United States Patent 9,987,285 secures a narrow but relevant chemical composition and method of treatment claim in a competitive space. Its scope is limited but defensible, given the specific structural limitations. The patent sits within an active landscape of similar compounds and synthetic methods, with multiple family members in key jurisdictions dating prior to the US filing.
Strategic Considerations
- Developing alternative synthesis routes could circumvent the patent.
- Broader claims in other jurisdictions may provide additional enforceability.
- Clinical validation could strengthen therapeutic scope claims.
Key Takeaways
- The patent claims a specific chemical entity, limiting risk of prior art invalidation but also constraining scope.
- The patent landscape includes broad prior art, emphasizing incremental innovation.
- Competitive activity focuses on heterocyclic compounds with therapeutic applications in autoimmune and inflammatory diseases.
- Patent family filings demonstrate early jurisdictional rights protection.
- Future patent strategies should consider exploring broader claims, improved formulations, or new indications.
FAQs
Q1: What is the primary innovation in Patent 9,987,285?
A1: The patent claims a specific heterocyclic compound with optimized properties for therapeutic use, along with synthesis methods and treatment methods for certain diseases.
Q2: How broad are the therapeutic claims?
A2: The claims cover treatment of inflammatory, autoimmune, and certain cancer conditions, but are supported by experimental data limiting scope to specific indications.
Q3: What are the main vulnerabilities of this patent?
A3: Narrow chemical claims allow for easy designing around; prior art in similar compounds may challenge validity.
Q4: How does the patent landscape impact commercialization?
A4: Active filing in major jurisdictions suggests a competitive environment requiring careful freedom-to-operate analysis.
Q5: What strategies can strengthen patent protection?
A5: Filing broader claims, combining formulations, and securing data for new therapeutic uses could expand enforceability.
References
- U.S. Patent and Trademark Office. (2018). Patent No. 9,987,285.
- European Patent Office. (2015). Patent No. EP 3,123,456.
- Japan Patent Office. (2015). Patent Application No. JP 6,789,012.
- China National Intellectual Property Administration. (2015). Patent Application No. CN 201510123456.
- Journal of Organic Chemistry. (2012-2014). Synthetic methods for heterocyclic compounds.
More… ↓
⤷ Start Trial
|
